Peritransplant molecular MRD monitoring by targeted NGS in patients with FLT3-ITD-mutated acute myeloid leukemia.
- DOI
- 10.1182/bloodadvances.2026020264
- Published
- 2026 Aug 25
- Container
- Blood advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2026020264,
title = {Peritransplant molecular MRD monitoring by targeted NGS in patients with FLT3-ITD-mutated acute myeloid leukemia.},
author = {Hu X and Zhao Y and Jiang C and Fan Y and Shi J and Luo Y and Yu J and Lai X and Liu L and Ye Y and Liang J and Huang X and Zheng Z and Huang H and Shi W and Zhao Y},
year = {2026},
journal = {Blood advances},
doi = {10.1182/bloodadvances.2026020264},
url = {https://doi.org/10.1182/bloodadvances.2026020264}
}RIS
TY - JOUR TI - Peritransplant molecular MRD monitoring by targeted NGS in patients with FLT3-ITD-mutated acute myeloid leukemia. AU - Hu X AU - Zhao Y AU - Jiang C AU - Fan Y AU - Shi J AU - Luo Y AU - Yu J AU - Lai X AU - Liu L AU - Ye Y AU - Liang J AU - Huang X AU - Zheng Z AU - Huang H AU - Shi W AU - Zhao Y PY - 2026 JO - Blood advances DO - 10.1182/bloodadvances.2026020264 UR - https://doi.org/10.1182/bloodadvances.2026020264 ER -
APA
X, H., Y, Z., C, J., Y, F., J, S., Y, L., J, Y., X, L., L, L., Y, Y., J, L., X, H., Z, Z., H, H., W, S., & Y, Z. (2026). Peritransplant molecular MRD monitoring by targeted NGS in patients with FLT3-ITD-mutated acute myeloid leukemia.. Blood advances. https://doi.org/10.1182/bloodadvances.2026020264
Source records
- pubmed · retrieved 2026-09-25T21:27:20.795Z